Company Introduction

Company Head Image Zoom

Company Head Image

FineCo Ltd. is a young company that develops new drugs, neutraceuticals and functional cosmetics by combining state-of-the-art technology with natural resources, especially Oriental herbs and marine resources, The company works with cooperation global R&D network like European drug development companies, American universities and Korean and Japanese scientists. FineCo takes aim at developing modernized herbal products supported by scientific research in global standards, which can be used in worldwide market. The current major focuses of FineCo are natural compounds for enhancing immune system, treatingOsteoporosis, treating Alzheimer disease and Bio-materials such as Astaxanthin, high purity DHA/EPA, Xylitol and new Silk microstructure. FineCo is commercializing these compounds as Nutraceuticalsfirst,and simultaneously developing as new drugs. As one of key Venture Company evaluatedbyKorean government, FineCo is also participating in several National R&D programs and policy planning committee of Chunchon city government, even though its short history. FineCo moves forward to be Leading Company with the State-of-the-art Technology to produce safe and efficacious products to help people healthier and happier.

Detailed Company Information

  • Company NameFINECO CO.LTD
  • Business Type
  • Year Established
  • LocationSouth Korea
  • Main MarketsGermany,France,Greece,Malaysia,Singapore
  • Total Employees 1-50 People
  • Homepage www.fineco.net / www.lasoie.net
  • PresidentGarbeen Yim
  • Phone+82-33-258-6001
  • FAX+82-33-258-6003
  • AddressGangwon Technopark #201, 941 Yulmun-ri, Shinbuk-eup, Chuncheon, Gangwon, KOREA 200-821
  • Product Category Health & Medical > Herb Medicine

Additional Introduction

FineCo Ltd. is a young company that develops new drugs, neutraceuticals and functional cosmetics by combining state-of-the-art technology with natural resources, especially Oriental herbs and marine resources, The company works with cooperation global R&D network like European drug development companies, American universities and Korean and Japanese scientists. FineCo takes aim at developing modernized herbal products supported by scientific research in global standards, which can be used in worldwide market. The current major focuses of FineCo are natural compounds for enhancing immune system, treatingOsteoporosis, treating Alzheimer disease and Bio-materials such as Astaxanthin, high purity DHA/EPA, Xylitol and new Silk microstructure. FineCo is commercializing these compounds as Nutraceuticalsfirst,and simultaneously developing as new drugs. As one of key Venture Company evaluatedbyKorean government, FineCo is also participating in several National R&D programs and policy planning committee of Chunchon city government, even though its short history. FineCo moves forward to be Leading Company with the State-of-the-art Technology to produce safe and efficacious products to help people healthier and happier.